Tiziana Life Sciences (TLSA) Total Current Liabilities (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Total Current Liabilities for 9 consecutive years, with $11.2 million the latest figure, recorded in Q4 2025.

• Quarterly Total Current Liabilities rose 52.54% year-over-year to $11.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (up 52.54% YoY) and the FY2025 annual result came in at $11.2 million, up 52.54% from the prior year.
• Total Current Liabilities improved to $11.2 million in Q4 2025 per TLSA's latest filing, from $7.3 million in the prior quarter.
• Over the last five years, Total Current Liabilities for TLSA reached as high as $11.2 million in Q4 2025 and fell as low as $6.5 million in Q4 2023.
• A 5-year average of $7.9 million and a median of $7.3 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities dropped 11.7% — and 2025, when it jumped 52.54%.
• Year by year, Total Current Liabilities stood at $7.5 million in 2021, then dropped by 11.7% to $6.7 million in 2022, then decreased by 1.86% to $6.5 million in 2023, then grew by 12.37% to $7.3 million in 2024, then soared by 52.54% to $11.2 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $11.2 million, $7.3 million, and $6.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.